What is MindMaze?
Founded in 2012 and headquartered in Switzerland, MindMaze specializes in developing medical-grade virtual reality products aimed at stimulating neural recovery. The company's innovative platform integrates VR, computer graphics, brain imaging, and neuroscience to create intuitive human-machine interfaces. This focus positions MindMaze at the forefront of neurotechnology and rehabilitation solutions.
How much funding has MindMaze raised?
MindMaze has raised a total of $338.5M across 4 funding rounds:
Angel/Seed
$8.5M
Private Equity
$100M
Unspecified
$125M
Other Financing Round
$105M
Angel/Seed (2015): $8.5M, investors not publicly disclosed
Private Equity (2016): $100M led by Hinduja Group
Unspecified (2021): $125M supported by AlbaCore Capital
Other Financing Round (2022): $105M featuring AlbaCore Capital, Concord Health Partners, and Hambro Perks
Key Investors in MindMaze
Hinduja Group
The Hinduja Group is a diversified and transnational conglomerate company. Their investments span across industries including automotive, oil, banking, power, media, healthcare and more. The company is based in Mumbai, India.
AlbaCore Capital
AlbaCore Capital Group is a prominent European credit manager specializing in private credit and special situations investments. Based in London, AlbaCore operates with an entrepreneurial spirit and aims to be a long-term strategic partner for its investors and counterparties.
Concord Health Partners
CHP Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses with a focus on the healthcare sector. The company was incorporated in 2019 and is based in Summit, New Jersey.
What's next for MindMaze?
The substantial enterprise-level funding and recent strategic investment indicate MindMaze is poised for significant scaling and further product development. This capital infusion will likely accelerate the company's mission to advance brain technology and expand its market reach in the medical and human-machine interface sectors. Future endeavors may include enhanced clinical trials, broader commercialization of its VR-based neural recovery solutions, and continued innovation in its platform for intuitive human-machine interaction.
See full MindMaze company page
